Results 1 - 6 of 6 for subject:"GSK"
Sorted by Date || Sort by Relevance

February 16, 2009

Some time ago, I reported that Novartis had adopted a wikinomics approach to its diabetes research. After investing millions of dollars trying to unlock the genetic basis of type 2 diabetes, the company released all of its raw data on the Internet, for free. Hardly typical behavior for a pharmaceuti...
Wikinomics [ Feed - Focus - Exclude ] by Anthony D. Williams at 12:17 AM

February 02, 2009

According to Reuters, Honda (HMC) sales in the US fell in January. Reuters reports that the premier of China sees hopeful signs in his economy. Reuters reports that hard times make government jobs more attractive. Reuters reports that online games are moving into Western markets as cheap entertainme...
Tags: Palm , DNA , WMT , AAPL , GS , PFE , GM , MOT , SIRI , ms , GSK , HMC , RTP , Press Digest
24/7 Wall Street [ Feed - Focus - Exclude ] by 24/7 Wall St. at 4:04 AM

April 24, 2008

GlaxoSmithKline is buying a U.S. biotechnology company that is researching resveratrol, the chemical compound found in red wine that may retard the aging process. The CEO of the company says that "drugs that mimic resveratrol, by activating enzymes called sirtuins, could 'treat in a safe, natural ne...
Consumerist [ Feed - Focus - Exclude ] at 2:15 PM

April 23, 2008

The British drug maker said it would acquire a biotechnology company that is pursuing the notion that a compound found in red wine might retard aging....
NYT > Business [ Feed - Focus - Exclude ] at 1:40 AM

March 18, 2008

I recently wrote about the MOTHERS Act and the unnecessary scare tactics surrounding it. A Dallas-Fort Worth TV station picked up on the story and provided a short one-sided view of the issue, continuing to purport that the bill is......
depression introspection [ Feed - Focus - Exclude ] at 5:42 PM

February 06, 2008

The National Heart, Lung, and Blood Institute has stopped the intensive glucose lowering arm of the ACCORD trial due to excess mortality in that treatment arm. ACCORD was designed to evaluate the impact of different glucose and lipid-lowering strategies on cardiovascular events in more than 10,251 p...
PharmaGossip [ Feed - Focus - Exclude ] at 3:18 PM
Subscribe to this Search
Get this search in RSS

Add to My Yahoo!
Add to Google
Add to My AOL
Subscribe with Bloglines
Subscribe in NewsGator Online

Mobile
Subscribe on your mobile